In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Input: Consider Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Urgent Counter-Terrorism
Supplemental Appropriations Act, 2002''.

SEC. 2. STATEMENT OF APPROPRIATION.

The following sums are appropriated, out of any money in the
Treasury not otherwise appropriated, for fiscal year 2002, and for
other purposes.

TITLE I--APPROPRIATION AND TRANSFERS OF FUNDS

SEC. 101. APPROPRIATION.

In addition to the amounts provided in any other Act, there is
hereby appropriated $6,548,000,000 to the ''Defense Emergency Response
Fund'' only for the purpose of upgrading critical defense and
intelligence capabilities to fight the war on terrorism and to recover
from the attacks of September 11, 2001.

SEC. 102. TRANSFERS OF FUNDS.

Notwithstanding any other provision of law or this Act, within 15
days after the President makes an emergency designation under section
301 for any amount specified in any section of title II, the Secretary
of Defense shall transfer the requisite funds appropriated by section
101 to appropriate accounts in the Treasury in accordance with the
allocations specified in title II.

TITLE II--ALLOCATION OF FUNDS

SEC. 201. ANTI-TERRORISM INTELLIGENCE UPGRADES.

To upgrade and improve the effectiveness of counter-terrorism
intelligence collection and analysis, to better protect intelligence
resources from terrorist attack, and to accelerate the installation of
real-time linkages between intelligence systems and military
warfighting platforms, $2,001,000,000 of the funds appropriated in
section 101 shall be allocated as follows:
(1) $368,000,000 shall be available only to improve
Department of Defense and intelligence agency human
intelligence collection capabilities against terrorist
organizations to include additional manpower, additional
analytical capability, and agent operation expenses.
(2) $245,000,000 shall be available only to the Director of
Central Intelligence to support critical foreign counter-
intelligence force protection requirements and to provide
additional counter-terrorism assistance to the Federal Bureau
of Investigation in accordance with law.
(3) $80,000,000 shall be available only to the Director of
Central Intelligence to upgrade counter-terrorism intelligence
tasking, processing, exploitation, and dissemination
capabilities.
(4) $55,000,000 shall be available only to the Secretary of
Defense to upgrade counter-terrorism intelligence tasking,
processing, exploitation, and dissemination capabilities.
(5) $497,000,000 shall be available only to procure and
support the enhancement and deployment of additional
Intelligence, Surveillance, and Reconnaissance assets in
support of Operation Enduring Freedom and follow-on anti-
terrorist operations.
(6) $159,000,000 shall be available only to enhance Navy
and Air Force electronic networking of assets and time critical
targeting capabilities.
(7) $182,000,000 shall be available only to procure Link 16
systems for tactical ISR platforms to allow real time data
exchange between combat and command and control platforms.
(8) $415,000,000 shall be available only to the Director of
Central Intelligence, in consultation with the Secretary of
Defense, for intelligence agency physical security upgrades,
data survivability/continuity enhancements, and satellite
infrastructure improvements.

SEC. 202. CHEMICAL AND BIOLOGICAL WARFARE DEFENSE CAPABILITIES.

To upgrade and improve the ability of the United States to detect,
prevent and respond to chemical and biological warfare terrorist
attacks at home and abroad, $817,000,000 of the funds appropriated in
section 101 shall be allocated as follows:
(1) $307,000,000 shall be available only for rapid
development and/or procurement and deployment of biological
weapons detection systems and chemical/biological
decontamination equipment at key military and civilian
facilities.
(2) $82,000,000 shall be available only to accelerate
production of anthrax vaccines and smallpox vaccine samples, to
develop next generation anthrax vaccines, and to develop, test,
evaluate and procure new drug therapies to counter biological
threat agents.
(3) $185,000,000 shall be available only to equip existing
Army National Guard Weapons of Mass Destruction Civil Support
teams (WMD-CST teams) with mobile analytical laboratory
capabilities and to establish, train and equip additional WMD-
CST teams in the following States and territories in order to
complete the objective of establishing WMD-CST teams in each
State and territory:
(A) Alabama.
(B) Connecticut.
(C) Delaware.
(D) District of Columbia.
(E) Indiana.
(F) Kansas.
(G) Maryland.
(H) Michigan.
(I) Mississippi.
(J) Montana.
(K) Nebraska.
(L) New Hampshire.
(M) New Jersey.
(N) Nevada.
(O) North Carolina.
(P) North Dakota.
(Q) Oregon.
(R) Rhode Island.
(S) South Dakota.
(T) Tennessee.
(U) Utah.
(V) Vermont.
(W) West Virginia.
(X) Wisconsin.
(Y) Wyoming.
(Z) American Samoa.
(AA) Guam.
(BB) Puerto Rico and Virgin Islands.
(4) $40,000,000 shall be available only for biological
weapons proliferation prevention activities under the
Cooperative Threat Reduction Program. Of such funds,
$30,000,000 shall be transferred to ''Department of State--
Nonproliferation, Anti-Terrorism, Demining, and Related
Programs'' only for the purpose of supporting expansion of the
Biological Weapons Redirect and International Science and
Technology Centers programs to prevent former Soviet weapons
experts from emigrating to proliferant States and to
reconfigure former Soviet biological weapons production
facilities for peaceful uses.
(5) $68,000,000 shall be available only to support and
equip Marine Corps and Army chemical/biological warfare
response teams, including the procurement of additional mobile
decontamination units for these teams.
(6) $25,000,000 shall be available only for the Army
Chemical Stockpile Emergency Preparedness Program for State and
Federal technical assistance projects to ensure public safety
at chemical weapons storage facilities in the following States:
(A) Alabama.
(B) Arkansas.
(C) Colorado.
(D) Illinois.
(E) Indiana.
(F) Maryland.
(G) Kentucky.
(H) Oregon.
(I) Utah.
(J) Washington.
(7) $60,000,000 shall be available only for the procurement
of interoperable communications equipment to enable Army
emergency response teams to communicate with local emergency
response personnel.
(8) $50,000,000 shall be available only to implement short-
term facility repairs and improvements at the biocontainment
research laboratories of the Army Medical Research Institute of
Infectious Disease at Fort Detrick, Maryland, and the
facilities of the Army Institute of Pathology (AFIP) at the
Walter Reed Medical Center for the purpose of improving quick
response to demands for confirmatory and diagnostic testing of
potential biological threats and to accelerate the development
of treatments and vaccines against biological agents.

SEC. 203. SPECIAL FORCES COUNTER-TERRORISM CAPABILITY.

To upgrade and improve the ability of Special Forces to
successfully operate in Operation Enduring Freedom and future anti-
terrorist operations, $755,000,000 of the funds appropriated in section
101 shall be allocated as follows:
(1) $50,000,000 shall be available only for the procurement
of AN/PRC 112B survival radios for SOF rescue/extraction teams
to provide geo-location and low probability of intercept/
detection communications capability.
(2) $90,000,000 shall be available only to procure common
missile warning systems and improved conventional munitions
dispensers for the MH-47 and MH-60 aircraft to enhance rotary
wing survivability.
(3) $125,000,000 shall be available only to support
counter-terrorism full mission profile training to increase the
probability of mission success and decrease the possibility of
fratricide and to provide for shortfalls in flying hours
necessary to conduct such training and operations.
(4) $125,000,000 shall be available only to support
survivability and mission enhancement upgrades for C-130, MH-
53, and other SOF aircraft.
(5) $165,000,000 shall be available only to procure
nonstandard weapons and ammunition, unconventional equipment
and supplies, and other SOF unique counter-terrorism
enhancements to current capabilities.
(6) $200,000,000 shall be available only for SOCOM
equipment sustainment and refurbishment, and for procurement of
additional equipment.

SEC. 204. MUNITIONS AND ESSENTIAL EQUIPMENT REPLENISHMENT AND UPGRADES.

To ensure an adequate supply of precision guided weapons and other
weapons and munitions to fully prosecute Operation Enduring Freedom and
future potential anti-terrorist operations, and to provide for the
rapid development and deployment of promising anti-terrorist weapons,
WMD defense capabilities, and added support to key tactical warfare
systems, $912,000,000 of the funds appropriated in section 101 shall be
allocated as follows:
(1) $250,000,000 shall be available only to accelerate the
development and procurement of the tactical tomahawk cruise
missile.
(2) $180,000,000 shall be available only for the
procurement of laser-guided bomb kits.
(3) $125,000,000 shall be available only for procurement of
Army and Marine Corps small arms, small arms ammunition, and
night vision equipment.
(4)(A) $250,000,000 shall be available only to
''Operational Rapid Response Transfer Fund'', to remain
available for obligation until September 30, 2002, only for the
accelerated research, development, test, evaluation,
procurement, or deployment of military technologies, systems,
or other equipment necessary for improving the capability to
fight terrorism, protect the force, prepare for and respond to
terrorist attacks, or improve the capabilities of key tactical
systems.
(B) The Secretary of Defense may transfer funds under this
paragraph only to operation and maintenance accounts,
procurement accounts, or research, development, test and
evaluation accounts.
(C) Of the funds under this paragraph, $75,000,000 shall be
available only to support quick reaction activities to develop
and deploy promising new weapons and other WMD defense
capabilities that are recommended by the Department of Defense
Combating Terrorism Technology Task Force.
(D) The Secretary of Defense shall provide
written notification to the congressional defense committees prior to
the transfer of any amount under this paragraph in excess of $5,000,000
to a specific program, project, or activity.
(E) None of the funds under this paragraph may be obligated
for new start projects without prior notification to the
congressional defense committees in conformance with normal
reprogramming procedures and guidelines.
(5) $107,000,000 shall be available only to improve secure
communications capabilities of the Army Reserve components by
providing hardening, redundancy, storage, and information
assurance for network infrastructure.

SEC. 205. FORCE PROTECTION AND RECOVERY ACTIVITIES.

To upgrade physical security at Department of Defense and
intelligence agency installations, and to accelerate efforts to repair,
reconstruct, and renovate the Pentagon Reservation, $966,000,000 of the
funds appropriated in section 101 shall be allocated as follows:
(1)(A) $800,000,000 shall be available only to finance
accelerated building renovation activities for military command
centers and related activities at the Pentagon Reservation in
order to accelerate completion of the Pentagon renovation
project by at least 4 years from the current estimated
completion date of 2014.
(B) None of the funds under this paragraph shall be
obligated until 15 days after the Secretary of Defense has
submitted to the Congress a revised Pentagon renovation plan to
include estimated total costs by year and by function, a
comprehensive construction schedule, an assessment of the
security and operational benefits derived from an accelerated
schedule, and a certification that it is the Secretary's best
estimate that expenditure of such funds will accelerate the
final completion of the Pentagon renovation by at least 4
years.
(2) $45,000,000 shall be available only to procure patrol
boat equipment in support of enhanced Navy capabilities to
maintain threat standoff distances in foreign ports.
(3) $30,000,000 shall be available only to procure security
equipment identified by the Navy to be necessary to increase
the security of military sealift ships.
(4) $25,000,000 shall be available only to upgrade
firefighting self contained breathing equipment on Navy surface
ships.
(5) $31,000,000 shall be available only for Navy and Air
Force anti-access equipment.
(6) $25,000,000 shall be available only for Army anti-
access equipment.
(7) $10,000,000 shall be available only to modernize the
USS Comfort and USS Mercy hospital ships.

SEC. 206. ESSENTIAL AIRCRAFT UPGRADES.

To make essential upgrades and improvements in aircraft
capabilities for operating in the Central Asia region, $602,000,000 of
the funds appropriated in section 101 shall be allocated as follows:
(1) $88,000,000 shall be available only for the procurement
of additional decoys, armor, and other self-protection upgrades
for Air Force aircraft.
(2) $55,000,000 shall be available only for the procurement
of additional laser detecting sets and other self protection
and engine upgrades for Army (including SOCOM) helicopters.
(3) $48,000,000 shall be available only for the procurement
of crashworthy UH-60 helicopter extended range fuel tanks.
(4) $129,000,000 shall be available only to accelerate
planned electronic self protection, communications, navigation,
and engine upgrade modifications to combat search and rescue
helicopters.
(5) $67,000,000 shall be available only to procure
additional Litening targeting pods for AV-8B Harrier aircraft.
(6) $70,000,000 shall be available only to upgrade
strategic communications systems for the national airborne
command post.
(7) $145,000,000 shall be available only to improve the
reliability of B-52 electronics and the maintainability of B-2
surfaces.

SEC. 207. OPERATION ENDURING FREEDOM OPERATIONAL COSTS.

To ensure that the military services are not required to make
reductions in essential training, readiness, equipment maintenance,
quality of life, or research and development programs in order to pay
for the unbudgeted and unpredictable operational costs of Operation
Enduring Freedom, and to ensure that the aging equipment being used in
Operation Enduring Freedom is properly maintained, $495,000,000 of the
funds appropriated in section 101 shall be allocated as follows:
(1) $220,000,000 shall be available only to supplement the
defense working capital funds for increased fuel, base
operations, and training costs.
(2) $200,000,000 shall be available only for additional
spare parts to support Operation Enduring Freedom.
(3) $75,000,000 shall be available only for increased depot
maintenance requirements resulting from Operations Noble Eagle
and Enduring Freedom.

TITLE III--GENERAL PROVISIONS

SEC. 301. EMERGENCY DESIGNATION.

The entire amount specified in any section of title II--
(1) is designated by the Congress as an emergency
requirement pursuant to section 251(b)(2)(A) of the Balanced
Budget and Emergency Deficit Control Act of 1985; and
(2) shall be available only if an official budget request
for the entire amount contained in such section, that includes
designation of the entire amount as an emergency requirement as
defined in the Balanced Budget and Emergency Deficit Control
Act of 1985, is transmitted by the President to the Congress.

SEC. 302. REPORTING REQUIREMENT.

Within 15 days after the President makes an emergency designation
under section 301 for the amount specified in any section of title II,
the Secretary of Defense shall provide to the Congress a report
specifying the accounts to which the funds involved are to be
transferred and project level budget justifications for each transfer.

SEC. 303. MERGER OF AMOUNTS.

Funds transferred under this Act shall be merged with, and shall be
available for the same time period as, the appropriations to which the
funds are transferred.

SEC. 304. AUTHORIZATION OF FUNDS FOR INTELLIGENCE ACTIVITIES.

Funds transferred under this Act to accounts for intelligence
activities are deemed to be specifically authorized by the Congress for
purposes of section 504 of the National Security Act of 1947 (50 U.S.C.
414).

Output: Urgent Counter-Terrorism Supplemental Appropriations Act, 2002 - Appropriates additional funds for FY 2002 to the Defense Emergency Response Fund solely for upgrading critical defense and intelligence capabilities to fight the war on terrorism and recover from the terrorist attacks of September 11, 2001.Allocates such funds to the following categories: (1) anti-terrorism intelligence upgrades, including funds for the Department of Defense and the Central Intelligence Agency; (2) chemical and biological warfare defense capabilities, including funds for detection systems, vaccines, mobile laboratories, and public safety at chemical weapons storage facilities; (3) special forces counter-terrorism capability, including for survival radios, common missile warning systems, and nonstandard and unconventional weapons and equipment; (4) munitions and essential equipment replenishment and upgrades; (5) force protection and recovery activities, including renovations of the Pentagon Reservation; (6) essential aircraft upgrades; and (7) Operation Enduring Freedom operational costs.Designates all such funds as an emergency requirement under the Balanced Budget and Emergency Deficit Control Act of 1985, limiting their availability unless Congress receives a presidential budget request for the entire amount in such category.

Input: Consider Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Helping Effective Antibiotics Last
Act of 2015'' or the ''HEAL Act''.

SEC. 2. APPROVAL OF CERTAIN DRUGS FOR USE IN A WELL-DEFINED POPULATION
OF PATIENTS.

(a) Approval of Certain Antibacterial.--Section 505 of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended by adding at
the end the following:
''(x) Approval of Certain Antibacterial Drugs for Use in a Well-
Defined Population of Patients.--
''(1) Unmet medical need defined.--In this subsection, the
term 'unmet medical need' means that the antibacterial drug
involved--
''(A) has improved efficacy, as demonstrated in
adequate, well-controlled studies in humans, for
specific diseases or conditions, where current
therapies have been shown to be less effective;
''(B) has clinically meaningful decreased harms,
demonstrated in adequate, well-controlled studies in
humans, for diseases or conditions, where current
therapies have unacceptable adverse effects; or
''(C) has improved convenience, as demonstrated in
adequate, well-controlled studies in humans, where
improved convenience results in improved effectiveness
or decreased harms.
''(2) Approval.--Upon receipt of an application under
subsection (b) for an antibacterial drug that is intended to
treat a serious or life-threatening disease or condition,
irrespective of whether the drug is intended to address an
unmet medical need, the Secretary--
''(A) may approve the drug under subsection (c)
only for treating a well-defined population of
patients, and based upon the results of clinical trials
inclusive of human subjects representative of such
well-defined population;
''(B) in determining whether to grant such
approval, shall rely on superior outcomes over
available therapies based on direct measures of patient
benefits, as demonstrated in adequate, well-controlled
studies in the well-defined patient population, such
as--
''(i) decreased mortality;
''(ii) irreversible morbidity; or
''(iii) validated surrogate endpoints that
reflect mortality or irreversible morbidity;
and
''(C) shall require the labeling of drugs approved
pursuant to this subsection to prominently include in
the prescribing information required by section 201.57
of title 21, Code of Federal Regulations (or any
successor regulation)--
''(i) the population of patients with
respect to which the added benefit over
available therapies is expected as studied in
adequate, well-controlled studies that form the
basis for approval; and
''(ii) the method for identifying members
of that population.
''(3) Risk evaluation and mitigation strategy.--The
Secretary--
''(A) shall require a risk evaluation and
mitigation strategy (REMS) under section 505-1 for each
drug approved under this subsection; and
''(B) may include in any such strategy additional
elements to assure the safe use of the drug under
subsections (e) and (f) of section 505-1.
''(4) Rule of construction.--Nothing in this subsection
shall be construed to alter the standards of evidence under
subsection (c) or (d) (including the substantial evidence
standard in subsection (d)). Subsections (c) and (d) and such
standards of evidence apply to the review and approval of drugs
under this subsection, including whether a drug is safe and
effective. Nothing in this subsection shall be construed to
limit the authority of the Secretary to approve products
pursuant to this Act and the Public Health Service Act as
authorized prior to the date of enactment of this subsection.
''(5) Effective immediately.--The Secretary shall have the
authorities vested in the Secretary by this subsection
beginning on the date of enactment of this subsection,
irrespective of when and whether the Secretary promulgates
final regulations to carry out this subsection.''.
(b) Licensure of Certain Biological Products.--Section 351(j) of
the Public Health Service Act (42 U.S.C. 262(j)) is amended--
(1) by striking ''(j)'' and inserting ''(j)(1)'';
(2) by inserting ''505(x),'' after ''505(p),''; and
(3) by adding at the end the following:
''(2) In applying section 505(x) of the Federal Food, Drug, and
Cosmetic Act to the licensure of biological products under this
section--
''(A) references to an antibacterial drug with added
benefits over available therapies for a well-defined population
that is intended to treat a serious or life-threatening disease
or condition shall be construed to refer to biological products
with added benefits over available therapies for a well-defined
population intended to treat a bacterial infection associated
with a serious or life-threatening disease; and
''(B) references to an application submitted under section
505(b) of such Act and to approval of a drug under section
505(c) of such Act shall be construed to refer to an
application submitted under subsection (a) of this section and
to licensure of a biological product under such subsection (a),
respectively.''.
(c) Monitoring.--Title III of the Public Health Service Act is
amended by inserting after section 317T (42 U.S.C. 247b-22) the
following:

''SEC. 317U. MONITORING OF ANTIBACTERIAL DRUG USE, PATIENT OUTCOMES,
AND RESISTANCE.

''(a) Monitoring.--The Secretary, acting through the Director of
the Centers for Disease Control and Prevention, shall use the National
Healthcare Safety Network or another appropriate monitoring system to
monitor--
''(1) changes in patient outcomes such as mortality and
irreversible morbidity causally related to antibacterial
resistance; and
''(2) changes in bacterial resistance to drugs in relation
to patient outcomes.
''(b) Public Availability of Data.--The Secretary, acting through
the Director of the Centers for Disease Control and Prevention, shall
make the data derived from monitoring under this section publicly
available for the purposes of--
''(1) improving the monitoring of important trends in
patient outcomes in relation to antibacterial resistance; and
''(2) ensuring appropriate stewardship of antibacterial
drugs, including those receiving approval or licensure for a
well-defined population pursuant to section 505(x) of the
Federal Food, Drug, and Cosmetic Act.''.

SEC. 3. SUSCEPTIBILITY TEST INTERPRETIVE CRITERIA FOR MICROBIAL
ORGANISMS.

(a) In General.--Section 511 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 360a) is amended to read as follows:

''SEC. 511. SUSCEPTIBILITY TEST INTERPRETIVE CRITERIA FOR MICROBIAL
ORGANISMS.

''(a) In General.--The Secretary shall--
''(1) identify upon approval or licensing of antibacterial
drugs (including biological products intended to treat a
bacterial infection and other types of antimicrobial drugs, as
deemed appropriate by the Secretary), including qualified
infectious disease products, susceptibility test interpretive
criteria for such drugs based upon patient outcomes of
mortality and morbidity from adequate and well-controlled
studies and such other confirmatory evidence as the Secretary
deems necessary; and
''(2) update, consistent with subsection (b), such criteria
as needed based upon scientific evidence of changes in patient
outcomes.
''(b) Responding to Changes in Patient Outcomes To Evaluate
Susceptibility Test Interpretive Criteria.--
''(1) In general.--As needed based on evidence related to
changes in patient outcomes, the Secretary shall--
''(A) evaluate any new scientific studies on
changes in patient outcomes in relation to
susceptibility test interpretive criteria; and
''(B) publish on the public Website of the Food and
Drug Administration a notice--
''(i) presenting suggested new or updated
interpretive criteria; and
''(ii) if needed, hold a public advisory
committee to discuss scientific evidence
related to changes in interpretative criteria.
''(2) Annual compilation of notices.--Each year, the
Secretary shall compile the notices published under paragraph
(1)(B) noting any changes from prior notices and publish such
compilation in the Federal Register.
''(c) Definition.--In this section, the term 'susceptibility test
interpretive criteria' means one or more specific values which
characterize patient outcomes in relation to the degree to which
bacteria or other microbes are more resistant to treatment as measured
by patient outcomes.''.
(b) Conforming Amendment.--Section 1111 of the Food and Drug
Administration Amendments Act of 2007 (42 U.S.C. 247d-5a; relating to
identification of clinically susceptible concentrations of
antimicrobials) is repealed.
(c) Report to Congress.--Not later than one year after the date of
enactment of this Act, the Secretary of Health and Human Services shall
submit to the Committee on Energy and Commerce of the House of
Representatives and the Committee on Health, Education, Labor, and
Pensions of the Senate a report on the progress made in implementing
section 511 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
360a), as amended by this section.

SEC. 4. REQUIRING DEMONSTRATION OF SUPERIOR OUTCOMES FOR QUALIFIED
INFECTIOUS DISEASE PRODUCTS TO RECEIVE AN EXTENDED
EXCLUSIVITY PERIOD.

Section 505E(g) of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 355f(g)) is amended by striking ''means an antibacterial or
antifungal drug for human use intended to treat'' and inserting ''means
an antibacterial or antifungal drug for human use that is demonstrated
to produce superior outcomes over available therapies, based on direct
measures of patient benefits in clinical trials, and that is intended
to treat''.

SEC. 5. GUIDANCE ON TARGET PRODUCT PROFILES.

Not later than 18 months after the date of enactment of this Act,
the Commissioner of Food and Drugs, in consultation with the
Administrator of the Centers for Medicare & Medicaid Services, the
Director of the Indian Health Service, the Secretary of Defense, and
the Secretary of Veterans Affairs, shall issue guidance on the
development of target product profiles for novel antibacterial drugs
focused on public health priorities.

Output: Helping Effective Antibiotics Last Act of 2015 or the HEAL Act This bill amends the Federal Food, Drug, and Cosmetic Act to allow the Food and Drug Administration (FDA) to approve an antibacterial drug or biological product that is intended to treat a serious or life-threatening condition only for treating a well-defined population of patients. To be approved, the antibacterial product must produce superior outcomes over available therapies in the well-defined patient population. A product approved by this pathway must include in its prescribing information the population of patients expected to benefit from using the product and the method for identifying members of that population. The FDA must require each product to have a risk evaluation and mitigation strategy. The Centers for Disease Control and Prevention must monitor changes to bacterial drug resistance and changes to patient outcomes caused by bacterial drug resistance. Upon approval of antibacterial products, the FDA must identify susceptibility test interpretive criteria (the drug concentrations where a type of bacteria is categorized as susceptible, intermediate, or resistant) and update the criteria as needed based upon evidence of changes in patient outcomes. To be eligible for an exclusivity period extension, a qualified infectious disease product must be demonstrated to produce superior outcomes over available therapies. The FDA must issue guidance on the development of target product profiles for antibacterial drugs.

Input: Consider Input: SECTION 1. PURPOSES.

The purposes of this Act are--
(1) to augment law enforcement services and community
policing efforts by providing accessible crisis intervention
services for children who are involved in violent incidents,
and training for law enforcement officers in child development,
family, and cultural issues;
(2) to facilitate interaction between law enforcement
agencies, child and family service organizations, local
educational agencies, and other community members for the
purpose of building coalitions for the prevention of community
violence;
(3) to provide mentors for high-risk children and youth;
(4) to promote conflict resolution training for children
and youth; and
(5) to identify children and families at high risk for
developing behavioral or emotional problems resulting from
exposure to community violence and provide mental health and
other support services to such children and families, including
crisis intervention for child witnesses and victims of
violence.

SEC. 2. GRANT AUTHORIZATION.

(a) Establishment.--(1) The Attorney General, in consultation with
the Secretary of Health and Human Services, and where appropriate the
Secretary of Education, is authorized to award grants to States for use
by local law enforcement agencies for the establishment of law
enforcement and child and family services partnership programs to carry
out activities described in section 1.
(2) In awarding grants described in paragraph (1), the Attorney
General shall give priority to States that have law enforcement
agencies that--
(A) are engaged in community-based policing; and
(B) intend to target programs for disadvantaged
communities.
(b) Grant Distribution.--The Attorney General shall, to the extent
practicable, achieve an equitable distribution of assistance among the
urban and rural areas of the United States.
(c) Grant Amount.--A grant awarded under this Act shall be of
sufficient size and scope to adequately support programs authorized
under section 2.
(d) Duration.--A grant made under this Act shall be for a period of
not less than 2 years.

SEC. 3. USES OF FUNDS.

(a) In General.--Grants made under this Act to the States for use
by law enforcement agencies shall be used--
(1) to provide 24-hour response to crisis situations
affecting children and youth;
(2) to provide training for law enforcement officers
jointly taught by law enforcement officers and child guidance
professionals that includes instruction by child and family
service organizations in the basic principles of human
behavior, child psychology, and family systems;
(3) to develop or expand community activities for children
and families that are designed jointly by the law enforcement
and child and family services partnership, including conflict
resolution training programs for children and youth, after-
school activity and neighborhood recreation programs, and
parent support groups led jointly by child guidance and law
enforcement professionals;
(4) to establish weekly case conferences by a team of child
guidance professionals and law enforcement officers;
(5) to provide formal mentoring programs; or
(6) to assist and support the local educational agency
located in or near the community that the partnership serves in
developing and implementing conflict resolution programs.
(b) Limitation.--Of the total amount of funds made available under
this Act for each fiscal year, not more than 10 percent of such funds
may be used to implement the mentoring and conflict resolution programs
established by paragraphs (5) and (6) of subsection (a).

SEC. 4. APPLICATIONS.

(a) State Applications.--To request a grant under this Act a State
shall--
(1) prepare and submit to the Attorney General an
application in such form, at such time, and in accordance with
such procedures, as the Attorney General shall establish;
(2) provide an assurance that funds received under this Act
shall be used to supplement, not supplant, non-Federal funds
that would otherwise be available for programs funded under
this Act; and
(3) use the office designated under section 507 of the
Omnibus Crime Control and Safe Streets Act of 1968(42 U.S.C.
3757) to--
(A) prepare the application as required under this
section; and
(B) administer grant funds received under this Act,
including review of spending, processing, progress,
financial reporting, technical assistance, grant
adjustments, accounting, auditing, and fund
disbursement.
(b) Local Applications.--(1) To request funds under this Act from a
State, the chief executive of a law enforcement agency shall submit an
application to the office designated under subsection (a).
(2) Each application under paragraph (1) shall include--
(A) assurances that there is a partnership established
between the law enforcement agency and a child and family
service organization;
(B) assurances that the applicant has coordinated with
other segments of the community to ensure that the partnership
efforts complement existing community anti-violence efforts;
(C) assurances that programs developed shall maintain
confidentiality for all individuals served;
(D) assurances that adequate resources for training of law
enforcement officers and professional consultation services for
children and families, including professionals licensed to
provide child and family evaluations and treatment, will be
provided;
(E) assurances that funds received under this Act shall be
used to supplement, not supplant, non-Federal funds that would
otherwise be available for programs funded under this Act; and
(F) assurance that the partnership shall provide local
matching funds in accordance with the Federal share
requirements under section 5.

SEC. 5. ADMINISTRATIVE PROVISIONS.

(a) In General.--(1) The Federal share of a grant made under this
Act may not exceed--
(A) with respect to the first fiscal year, 75 percent of
the total costs of the projects described in the application
submitted under section 4 for such fiscal year;
(B) with respect to the second fiscal year, 70 percent of
the total costs of the projects described in the application
submitted under section 4 for such fiscal year; and
(C) with respect to any subsequent fiscal year, 60 percent
of the total costs of the projects described in the application
submitted under section 4 for such fiscal year.
(2) The Attorney General may accept the value of in-kind
contributions made by the grant recipient as a part or all of the non-
Federal share of grants.
(b) Technical Assistance.--The National Institute of Justice may
provide training and technical assistance to law enforcement and child
and family service partnerships.
(c) Administrative Costs.--A State or law enforcement agency may
use not more than 5 percent of the funds it receives from this Act for
administrative expenses.

SEC. 6. EVALUATIONS AND REPORTS.

(a) Evaluation.--The Attorney General shall conduct evaluations to
determine the effectiveness of the programs funded under this Act.
(b) Reports and Evaluations.--
(1) Interim.--Not later than December 31, 1995, the
Attorney General shall prepare and submit to the Committees on
the Judiciary of the House and Senate an interim progress
report based on information reported by the grantees and the
results (as of the date of the submission of such report) of
the evaluation conducted under subsection (a).
(2) Final.--Not later than December 31, 1998, the Attorney
General shall prepare and submit to the Committees on the
Judiciary of the House and Senate a review and summary of the
results of the evaluation conducted under subsection (a).

SEC. 7. DEFINITIONS.

For purposes of this Act, the following definitions apply:
(1) Child and family service organization.--The term
''child and family service organization'' means a public or
private nonprofit entity (such as child guidance centers, child
psychiatry or child psychology departments of hospitals or
university medical centers, or community mental health centers
providing child and family services) that provides mental
health services to children and families and that meets
nationally recognized guidelines (such as guidelines prescribed
for mental health centers and for child welfare and family
service agencies) with respect to the services provided to
children and families.
(2) Community-based policing.--The term ''community-based
policing'' means a commitment and an effort (within the
confines of budget restrictions) made by a law enforcement
agency to establish or expand cooperative efforts between the
police and a community in order to increase police presence in
the community, including--
(A) developing innovative neighborhood-oriented
policing programs and community-based crime-prevention
programs; and
(B) creating decentralized police substations
throughout the community to encourage interaction and
cooperation between the public and law enforcement
personnel on a local level, including the permanent
assignment of officers to a specific neighborhood or
substation.
(3) Formal mentoring program.--The term ''formal mentoring
program'' means a community partnership with corporations,
universities, labor organizations, nonprofit entities (such as
professional societies) or government agencies which recruits
and trains individuals representative of the cultural diversity
of their community, and includes individuals such as police
officers, child and family services staff, and community and
business leaders, to serve as role models for high-risk
children and youth.
(4) Law enforcement agency.--The term ''law enforcement
agency'' means an entity that serves a specific community and
has the legal responsibility of policing the activities of such
community.
(5) Law enforcement and child and family services
partnership.--The term ''law enforcement and child and family
services partnership'' means a cooperative agreement between a
law enforcement agency and a child and family service
organization.
(6) Mentor.--The term ''mentors'' means individuals
representative of the cultural diversity of the community, and
includes individuals such as police officers, child and family
services staff, and community and business leaders, who are
recruited and trained by a formal mentoring program to serve as
role models for high-risk children and youth.

SEC. 8. AUTHORIZATION OF APPROPRIATIONS.

There are authorized to be appropriated to carry out this Act,
$10,000,000 for fiscal year 1994, and such sums as may be necessary for
each of the fiscal years 1995 through 1998.
Output: Authorizes the Attorney General to award grants to States for use by local law enforcement agencies for the establishment of law enforcement and child and family services partnership programs to: (1) augment law enforcement services and community policing efforts by providing accessible crisis intervention services for children who are involved in violent incidents and training for law enforcement officers (officers) in child development, family, and cultural issues; (2) facilitate interaction between law enforcement agencies, child, and family service organizations, local educational agencies, and other community members for the purpose of building coalitions for the prevention of community violence; (3) provide mentors for high-risk children and youth; (4) promote conflict resolution training for children and youth; and (5) identify children and families at high risk for developing behavioral or emotional problems resulting from exposure to community violence and provide mental health and other support services to such children and families, including crisis intervention for children witnesses and victims of violence.
Directs the Attorney General, in awarding such grants, to give priority to States that have law enforcement agencies that: (1) are engaged in community-based policing; and (2) intend to target programs for disadvantaged communities.
Authorizes the use of such grants to: (1) provide 24-hour response to crisis situations affecting children and youth, training for officers jointly taught by officers and child guidance professionals, and formal mentoring programs; (2) develop or expand community activities for children and families that are designed jointly by the law enforcement and child and family services partnership; (3) establish weekly case conferences by a team of child guidance professionals and officers; and (4) assist and support the local educational agency located in or near the community the partnership serves in developing and implementing conflict resolution programs.
Sets forth provisions regarding: (1) limitations on the use of grant funds; (2) State and local application requirements; (3) the Federal share; and (4) evaluations and reporting requirements.
Authorizes the National Institute of Justice to provide training and technical assistance to law enforcement and child and family service partnerships.
Authorizes appropriations.